|
May 15
|
Sector Update: Health Care Stocks Advance Late Wednesday Afternoon
|
|
May 15
|
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
|
|
May 14
|
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
|
|
May 7
|
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
|
|
May 7
|
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Q1 2024 T2 Biosystems Inc Earnings Call
|
|
May 7
|
T2 Biosystems Inc (TTOO) Q1 2024 Earnings Call Transcript Highlights: Revenue Growth Amidst ...
|
|
May 6
|
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
|
|
May 6
|
T2 Biosystems Announces First Quarter 2024 Financial Results
|
|
May 6
|
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
|
|
Apr 24
|
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
|
|
Apr 11
|
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
|
|
Mar 28
|
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
|
|
Mar 20
|
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
|
|
Mar 19
|
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
|
|
Mar 18
|
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
|
|
Mar 12
|
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
|
|
Feb 15
|
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
|
|
Feb 15
|
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
|
|
Feb 15
|
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
|